You are here

Home » CERID Bibliography

CERID Bibliography

Export 111 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is T  [Clear All Filters]
Journal Article
Posavad CM, Wald A, Hosken N, Huang ML, Koelle DM, Ashley RL, Corey L. T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?. J Immunol. 2003 ;170(8):4380-8.
Durvasula R. Taking a Bite Out of Mosquitoes: A New Drug to Block Transmission of Malaria. J Infect Dis. 2013 .
Andrews-Polymenis HL, Bäumler AJ, McCormick BA, Fang FC. Taming the elephant: Salmonella biology, pathogenesis, and prevention. Infect Immun. 2010 ;78(6):2356-69.
Kay MK, Perti TR, Duchin JS. Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009. Emerg Infect Dis. 2011 ;17(9):1734-6.
Tobin DM, Ramakrishnan L. TB: the Yin and Yang of lipid mediators. Curr Opin Pharmacol. 2013 ;13(4):641-5.
Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM. T-cell immunity to human alphaherpesviruses. Curr Opin Virol. 2013 ;3(4):452-60.
Murphy SC, Kas A, Stone BC, Bevan MJ. A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc Natl Acad Sci U S A. 2013 ;110(15):6055-60.
Arroll TW, Centurion-Lara A, Lukehart SA, Van Voorhis WC. T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection. Infect Immun. 1999 ;67(9):4757-63.
Nepomuceno-Silva JL, Yokoyama K, de Mello LD, Mendonca SM, Paixão JC, Baron R, Faye JC, Buckner FS, Van Voorhis WC, Gelb MH, et al. TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi: cloning, trans-splicing, and prenylation studies. J Biol Chem. 2001 ;276(32):29711-8.
Magariños MP, Carmona SJ, Crowther GJ, Ralph SA, Roos DS, Shanmugam D, Van Voorhis WC, Agüero F. TDR Targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res. 2012 ;40(Database issue):D1118-27.
Zorzi P, Aplin AC, Smith KD, Nicosia RF. Technical Advance: The rat aorta contains resident mononuclear phagocytes with proliferative capacity and proangiogenic properties. J Leukoc Biol. 2010 ;88(5):1051-9.
Koelle DM, Reymond SN, Chen H, Kwok WW, McClurkan C, Gyaltsong T, Petersdorf EW, Rotkis W, Talley AR, Harrison DA. Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J Virol. 2000 ;74(23):10930-8.
Mercado-Curiel RF, Palmer GH, Guerrero FD, Brayton KA. Temporal characterisation of the organ-specific Rhipicephalus microplus transcriptional response to Anaplasma marginale infection. Int J Parasitol. 2011 ;41(8):851-60.
Levy SB, McMurry LM, Roberts MC. Tet protein hybrids. Antimicrob Agents Chemother. 2005 ;49(7):3099.
Soge OO, Roberts MC. tet(M)-carrying Haemophilus influenzae as a potential reservoir for mobile antibiotic resistance genes. J Antimicrob Chemother. 2011 ;66(7):1642-3.
Roberts MC. Tetracycline therapy: update. Clin Infect Dis. 2003 ;36(4):462-7.
Novak EJ, Liu AW, Gebe JA, Falk BA, Nepom GT, Koelle DM, Kwok WW. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol. 2001 ;166(11):6665-70.
Eastman RT, Buckner FS, Yokoyama K, Gelb MH, Van Voorhis WC. Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J Lipid Res. 2006 ;47(2):233-40.
Hann CL, Daniel VC, Sugar EA, Dobromilskaya I, Murphy SC, Cope L, Lin X, Hierman JS, Wilburn DL, D Watkins N, et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res. 2008 ;68(7):2321-8.
Gelb MH, Brunsveld L, Hrycyna CA, Michaelis S, Tamanoi F, Van Voorhis WC, Waldmann H. Therapeutic intervention based on protein prenylation and associated modifications. Nat Chem Biol. 2006 ;2(10):518-28.
Hübel K, Dale DC, W Liles C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and inte. J Infect Dis. 2002 ;185(10):1490-501.
Van Voorhis WC. Therapy and prophylaxis of systemic protozoan infections. Drugs. 1990 ;40(2):176-202.
Smith RA, Raugi DN, Pan C, Coyne M, Hernandez A, Church B, Parker K, Mullins JI, Sow PSalif, Gottlieb GS. Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens. PLoS One. 2012 ;7(9):e45372.
Lee H-C, Headley MB, Loo Y-M, Berlin A, Gale M, Debley JS, Lukacs NW, Ziegler SF. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012 ;130(5):1187-1196.e5.
Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med. 1993 ;329(13):936-47.

Pages